Corvus Pharmaceuticals (CRVS) Earnings Date & Reports

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CRVS is expected to report earnings to -14 cents per share on August 11

Corvus Pharmaceuticals CRVS Stock Earnings Reports

Q2'26

Est.

$-0.15

Q1'26

Est.

$-0.15

Q4'25

Missed

by $0.02

Q3'25

Beat

by $0.01

Q2'25

Beat

by $0.03

The last earnings report on May 07 showed earnings per share of -15 cents, meeting the estimate of -15 cents. With 3.40M shares outstanding, the current market capitalization sits at 1.22B.

View a ticker or compare two or three

Compare

CRVS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CRVS